Renaissance Capital logo

TetraLogic Pharmaceuticals Priced, Nasdaq: TLOG

Developing small molecule therapeutics for the treatment of cancer.

Industry: Health Care

First Day Return: 0.0%

Developing small molecule therapeutics for the treatment of cancer.
IPO Data
IPO Date 12/11/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Malvern, PA, United States
Founded 2001
Employees at IPO 20
Website www.tetralogicpharma.com

TetraLogic Pharmaceuticals (TLOG) Performance

Created with Highcharts 10.3.2Chart context menuTLOG vs. IPO Index (IPOUSA)2014201520162017201820192020202120222023202420250%+ 200%-200%+ 400%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index